Prof. Christos Papaneophytou holds a Diploma in Chemical Engineering (2000), an MSc (2004), and a PhD (2008) in Biochemistry, all from Aristotle University of Thessaloniki (AUTH), Greece. Following his doctoral studies, he undertook postdoctoral research at AUTH (2009–2011), the Center for Research and Technology in Thessaly, Greece (2011–2014), and the Cyprus Institute of Neurology and Genetics (2014–2015). He is currently a Professor of Biochemistry in the Department of Life Sciences at the School of Life and Health Sciences, University of Nicosia (UNIC), where he also serves as Associate Dean. His research primarily focuses on drug discovery for the treatment of rheumatoid arthritis, cancer, and respiratory tract infections caused by rhinoviruses, adenoviruses, and SARS-CoV-2. Additionally, he is dedicated to identifying prognostic, diagnostic, and therapeutic biomarkers, including non-coding RNAs and proteins, for a variety of diseases, with particular interest in cardiovascular diseases and osteoarthritis. He is a co-founder of the non-Coding RNA Research Laboratory at UNIC and serves as its Associate Director. He has authored numerous peer-reviewed publications and book chapters and frequently presents at international scientific conferences. He is involved in several research projects funded by both international and national organizations. Furthermore, he serves as a reviewer for multiple scientific journals and as a guest editor for several high-impact journals.